Indirect effects of cytomegalovirus infection and the utility of utility of valganciclovir

被引：0
|
作者：
Martinez-Dolz, L. [1 ]
Sanchez Lazaro, I. JIgnacio Jose [1 ]
Domenech-Tort, M. D. [1 ]
Ten-Morro, F. [1 ]
Rosello-Lleti, E. [1 ]
Tarazon-Melguizo, E. [1 ]
Portoles-Sanz, M. [1 ]
Rivera-Otero, J. M. [1 ]
Salvador-Sanz, A. [1 ]
Almenar-Bonet, L. [1 ]
机构：
[1] Hosp Univ La Fe, Valencia, Spain
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [31] Valganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplantation
    Ticehurst, Erin Wade
    Trofe-Clark, Jennifer
    Blumberg, Emily
    Bloom, Roy D.
    TRANSPLANT RESEARCH AND RISK MANAGEMENT, 2010, 2 : 29 - 39
  • [32] Development of Cytomegalovirus (CMV) Infection during Ongoing Valganciclovir Therapy
    Patel, J.
    Kittleson, M.
    Kubak, B.
    Kawano, M.
    Davis, S.
    Moriguchi, J.
    Ardehali, A.
    Kobashigawa, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (02): : S66 - S67
  • [33] Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection
    Stockmann, Chris
    Roberts, Jessica K.
    Knackstedt, Elizabeth D.
    Spigarelli, Michael G.
    Sherwin, Catherine M. T.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2015, 11 (02) : 205 - 219
  • [34] The influence of valganciclovir prophylaxis on cytomegalovirus, infection after lung transplantation
    Hellemons, M. E.
    van der Bij, W.
    Erasmus, M. E.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S104 - S104
  • [35] Comparative Effects of Valganciclovir and Ganciclovir on the Congenital Cytomegalovirus Infection and Hearing Loss: A Randomized Controlled Trial
    Yang, Lili
    Qiu, Aijuan
    Wang, Jing
    Pan, Zhaojun
    IRANIAN JOURNAL OF PEDIATRICS, 2022, 32 (01)
  • [36] Effect on Hearing of Oral Valganciclovir for Asymptomatic Congenital Cytomegalovirus Infection
    Ciftdogan, Dilek Yilmaz
    Vardar, Fadil
    JOURNAL OF TROPICAL PEDIATRICS, 2011, 57 (02) : 132 - 134
  • [37] Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection
    Lombardi, G.
    Garofoli, F.
    Villani, P.
    Tizzoni, M.
    Angelini, M.
    Cusato, M.
    Bollani, L.
    De Silvestri, A.
    Regazzi, M.
    Stronati, M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2009, 28 (12) : 1465 - 1470
  • [38] Oral valganciclovir treatment in newborns with symptomatic congenital cytomegalovirus infection
    G. Lombardi
    F. Garofoli
    P. Villani
    M. Tizzoni
    M. Angelini
    M. Cusato
    L. Bollani
    A. De Silvestri
    M. Regazzi
    M. Stronati
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28 : 1465 - 1470
  • [39] Artesunate is Ineffective in Controlling Valganciclovir-Resistant Cytomegalovirus Infection
    Lau, Peter Kar Han
    Woods, Marion L.
    Ratanjee, Sharad Kanneyalal
    John, George Tharayil
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (02) : 279 - 279
  • [40] Valganciclovir treatment of newborns with symptomatic congenital cytomegalovirus (CMV) infection
    Lombardi, G.
    Di Comite, A.
    Decembrino, L.
    Barbarini, M.
    Regazzi, M.
    Villani, P.
    Cusato, M.
    Stronati, M.
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 479 - 479
12345